BMJ Open · 2018 · 66 citations · 34 references
MedicineCardiologyHealth EducationCardiac RehabilitationRehabilitationSelf-management SupportBehavior Change SupportCardiovascular Disease PreventionCardiovascular Risk ReductionHome-based RehabilitationLifestyle ModificationMobile Health ApplicationsBlood Pressure MonitoringCardiovascular Disease ManagementCardiovascular Risk Factor ModificationHome Blood Pressure MonitoringMobile Health SupportMobile Health TrackingPercutaneous Coronary Intervention CareRisk Monitoring
INTRODUCTION: The burden of cardiovascular disease (CVD) is rapidly increasing in developing countries, however access to cardiac rehabilitation and secondary prevention (CR/SP) in these countries is limited. Alternative delivery models that are low-cost and easy to access are urgently needed to address this service gap. The objective of this study is to investigate whether a smartphone and social media-based (WeChat) home CR/SP programme can facilitate risk factor monitoring and modification to improve disease self-management and health outcomes in patients with coronary heart disease (CHD), after percutaneous coronary intervention (PCI) therapy. METHODS AND ANALYSIS: We propose a single-blind, randomised controlled trial of 300 patients post-PCI with follow-up over 12 months. The intervention group will receive a smartphone-based and WeChat-based CR/SP programme providing education and support for risk factor monitoring and modification. SMART-CR/SP incorporates core components of modern CR/SP: physical activity tracking with interactive feedback and goal setting; education modules addressing CHD understanding and self-management; remote blood pressure monitoring and strategies to improve medication adherence. Furthermore, a dedicated data portal and a CR/SP coach will facilitate individualised supervision and counselling. The control group will receive usual care but no formal CR/SP programme. The primary outcome is change in exercise capacity measured by 6 minute walk test distance. Secondary outcomes include knowledge and awareness of CHD, risk factor status, medication adherence, psychological well-being and quality of life, major cardiovascular events, re-hospitalisations and all-cause mortality. To assess the feasibility and patients' acceptance of the intervention, a process evaluation will be performed at the conclusion of the study. ETHICS AND DISSEMINATION: Ethics approval was granted by both the Human Research Ethics Committee of Fudan University Zhongshan Hospital (HREC B2016-058) and Curtin University Human Research Ethics Office (HRE2016-0120). Results will be disseminated via peer-reviewed publications and presentations at conferences. CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR-INR-16009598; Pre-results.
34
Paul A. Harris, Robert Taylor, Robert J. Thielke et al. · Journal of Biomedical Informatics · 2008 · 51.7K citations · Full text
Kurt Kroenke, Robert L. Spitzer, Janet B. W. Williams · Journal of General Internal Medicine · 2001 · 44.2K citations · Full text
A Brief Measure for Assessing Generalized Anxiety Disorder
Robert L. Spitzer, Kurt Kroenke, Janet B. W. Williams et al. · Archives of Internal Medicine · 2006 · 31.5K citations
Nursing, Psychiatry, Psychology +17
A 12-Item Short-Form Health Survey
John E. Ware, Mark Kosinski, Susan Keller · Medical Care · 1996 · 17.1K citations